IDEAYA Biosciences Darovasertib Neoadjuvant Uveal Melanoma Clinical Program Update
| DATE: | September 23, 2024 |
|---|---|
| TIME: | 8:00 AM EDT |
| LOCATION: | Virtual |
About The Event
Event Agenda
- Welcome and Introduction
- Market Introduction: Annual Incidence of Uveal Melanoma (UM)
- Registrational Trial Design Based on FDA Type C Meeting Guidance
- Phase 2 Clinical Data Update
- Baseline Characteristics
- AE Profile
- Clinical Efficacy from Phase 2 company sponsored and IST
- Conclusion
- Q&A with Analysts